Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Anti-TNFα drugs are currently used in the treatment of patients with Crohn's disease. Studies have reported neurological side effects occurring after anti-TNFα treatment, including infliximab-induced complications.

Related Topics

    loading  Loading Related Articles